Arabic Arabic English English French French German German
dark

Kemin Granted U.S. Patent for Treatment of Human Immune Function

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has been granted a United States patent on the use of beta 1,3 glucan for modulating human immune function and treating intestinal inflammation. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Expansions and Hirings Spark Surge of Growth in BioCapital Region

Next Post

Sherlock Biosciences’ CRISPR SARS-CoV-2 Test Selected as Finalist in “On the Rise” and Honorable Mention in “Health and Pandemic Response” Categories of Fast Company’s 2021 World Changing Ideas Awards

Related Posts
Total
0
Share